L.J. Altfest & Co’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Buy |
18,402
+3,872
| +27% | +$416K | 0.23% | 79 |
|
|
2025
Q1 | $1.47M | Buy |
14,530
+402
| +3% | +$40.6K | 0.18% | 91 |
|
|
2024
Q4 | $1.26M | Buy |
14,128
+2,077
| +17% | +$186K | 0.16% | 98 |
|
|
2024
Q3 | $1.01M | Sell |
12,051
-372
| -3% | -$31.2K | 0.13% | 131 |
|
|
2024
Q2 | $957K | Buy |
12,423
+2,703
| +28% | +$208K | 0.13% | 119 |
|
|
2024
Q1 | $666K | Buy |
9,720
+3,243
| +50% | +$222K | 0.09% | 158 |
|
|
2023
Q4 | $374K | Sell |
6,477
-6,821
| -51% | -$394K | 0.05% | 224 |
|
|
2023
Q3 | $702K | Buy |
13,298
+208
| +2% | +$11K | 0.11% | 137 |
|
|
2023
Q2 | $708K | Sell |
13,090
-200
| -2% | -$10.8K | 0.11% | 135 |
|
|
2023
Q1 | $665K | Buy |
13,290
+17
| +0.1% | +$851 | 0.1% | 133 |
|
|
2022
Q4 | $614K | Buy |
13,273
+2,683
| +25% | +$124K | 0.1% | 139 |
|
|
2022
Q3 | $410K | Buy |
10,590
+37
| +0.4% | +$1.43K | 0.08% | 166 |
|
|
2022
Q2 | $393K | Buy |
+10,553
| New | +$393K | 0.07% | 172 |
|
|
2021
Q1 | – | Sell |
-25,164
| Closed | -$905K | – | 279 |
|
|
2020
Q4 | $905K | Buy |
25,164
+2,680
| +12% | +$96.4K | 0.22% | 85 |
|
|
2020
Q3 | $859K | Buy |
22,484
+3,366
| +18% | +$129K | 0.23% | 79 |
|
|
2020
Q2 | $671K | Buy |
19,118
+12,774
| +201% | +$448K | 0.19% | 86 |
|
|
2020
Q1 | $207K | Buy |
+6,344
| New | +$207K | 0.06% | 183 |
|